• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Anixa begins Phase Ib trial of breast cancer vaccine

cafead

Administrator
Staff member
  • cafead   Oct 27, 2022 at 11:22: AM
via Anixa Biosciences has begun a Phase Ib clinical trial of its preventative breast cancer vaccine.

Being carried out at the Cleveland Clinic in the US, the trial will assess the safety and observe the immune response in subjects.

article source